The FSP Model Tailored for Biotech

For emerging and mid-sized biotechs, scientific ambition is outpacing operational capacity. Functional Service Provider (FSP) partnership can close that gap, if the critical factors to successful FSP integration are understood.

61% of clinical development activities are outsourced by sponsors, on average. Outsourcing is a central operating model, not a tactical resource solution. Three structural forces are accelerating the need for this integrated approach:

• Lean sponsor teams needing scalable resourcing models
• Rising protocol complexity driving need for specialized expertise
• Cost and risk management pressures

What you'll take away

• Why lean teams, rising protocol complexity, and cost/risk management pressures are reshaping how sponsors outsource
• How full-service CRO, FSP, and hybrid models compare, and when each fits your stage
• Two real case studies: scaling biometrics capacity, and accelerating an FDA submission across 10 studies
• A three-tier governance model that keeps you in strategic control of every program

Download the eBook to explore the frameworks, technologies, and real-world examples shaping a modern biotech-focused FSP model.